Ground breaking robotic surgery has enabled researchers to remove a rare tumor from a patients neck. This patient is the first in the world to undergo the complex three-part, robotic-assisted surgery.
Browsing: Disease Area > Rare tumors
Larotrectinib becomes the first cancer drug to receive FDA breakthrough therapy designation for patients with a specific fusion of two genes in the cancer cell, no matter what cancer type.
One definition of rare cancers is that with an incidence of less than six cases per 100,000 population each year.…
In this report the authors discuss diagnosis and treatment of a patient with leiomyosarcoma of the stomach, whose disease progressed 2 years after he was disease-free following initial treatment.
Scientists have revealed that a human protein – identified as YTHDF2 – could prevent cancer by restricting the human herpes virus 8, otherwise known as Kaposi’s sarcoma-associated herpesvirus.
Patients with cancerous forms of gestational trophoblastic disease went into remission after treatment with pembrolizumab.
A team of scientists have bound gene editing CRISPR/Cas9 to nucleotide aptamers to selectively target and edit osteosarcoma cancer cells.
The largest genomics study of chordoma to date has discovered a gene mutation possessed by some patients which is a target for existing drugs known as PI3K inhibitors. Previously, these drugs have not been considered for chordoma.
Proper staging, early detection and accurate diagnosis all play a key role in successful treatment for cancer patients. Discover some of the treatment options for mesothelioma in this opinion piece.